Please enable Javascript
nmHSPC
Advertisement
Latest News
Read More
Advertisement
Prostate Cancer Knowledge Hubs
Curated clinical content on prostate cancer types, therapies, and technologies
Conference Coverage
Next-Generation Immunotherapy for NMIBC: QUILT 2.005 and QUILT 3.032
Patrick Soon-Shiong, MD
Non-Muscle Invasive Urothelial Carcinoma
|
May 10, 2024
Dr. Soon-Shiong provides an overview of the groundbreaking data related to nogapendekin alfa inbakicept for NMIBC.
Genomic Signatures Associated With Adverse Pathologic Features at Radical Prostatectomy
Eric Li, MD
Prostate Cancer Diagnostics
|
May 8, 2024
Dr. Li highlights the significance of adverse pathologic features at radical prostatectomy for AS-eligible patients.
Urinary MRD Detection for Predicting Recurrence, Response to Nadofaragene Firadenovec in BCG-Unresponsive NMIBC
Vikram M. Narayan, MD
Non-Muscle Invasive Urothelial Carcinoma
|
May 7, 2024
Continuing his discussion at the AUA 2024 Annual Meeting, Dr. Narayan highlights the latest news on nadofaragene firadenovec.
Nadofaragene Firadenovec for BCG-Unresponsive NMIBC: 5-Year Follow-Up
Vikram M. Narayan, MD
Non-Muscle Invasive Urothelial Carcinoma
|
May 7, 2024
Dr. Narayan breaks down the 5-year follow-up data on nadofaragene firadenovec for patients with BCG-unresponsive NMIBC.
Risk Score to Identify Optimal Patients for Adjuvant RT After Radical Prostatectomy
Zachary Bessette
Localized
|
May 6, 2024
Development of a novel risk score for early intensification approaches to RT or salvage RT for pN1 receiving RP.
Patient Selection, Counseling, and Improved Biomarkers, Imaging: Moving Forward From KEYNOTE-564
Sarah Psutka, MD, MSc
Renal Cell Carcinoma Diagnostics
|
May 7, 2024
Drs. Joyce and Psutka consider patient counseling for adjuvant RCC therapy, and biomarkers and imaging before treatment.
View Full Conference Coverage
Advertisement
Advertisement
Trending
Metabolites in Urine Samples Taken Before and Following Transurethral Resection of Bladder Tumor
Patrick Daly
Advanced Urothelial Carcinoma
|
September 20, 2022
Metabolites were shown to have “the highest potential for differences between urine levels in healthy and BC patients."
Read More
Investigating the Associations Between Smoking and Genetic Variants of Bladder Cancer
Patrick Daly
Advanced Urothelial Carcinoma
|
September 20, 2022
Smoking increased risk of urothelial carcinoma “more than expected” in patients with certain genetic risk factors.
Read More
Liquid Biopsy Biomarkers for Predicting Post-Radical Cystectomy Recurrence in Bladder Cancers
Patrick Daly
Advanced Urothelial Carcinoma
|
September 20, 2022
Researchers developed a model to predict bladder cancer recurrence by combining microRNA with a pathological factor.
Read More